Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
复制标题
成人同种异体造血细胞移植后的高铁蛋白血症:通过测定非转铁蛋白结合铁来量化铁负荷。
DOI:
10.1007/s12185-012-1252-1
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
Koichi Miyam
中科院分区:
文献类型:
--
作者:
Tatsunori Goto;Katsuya Ikuta;Yoshihiro Inamoto;Sonoko Kamoshita;Emi Yokohata;Daisuke Koyama;Koichi Onodera;Aika Seto;Keisuke Watanabe;Nobuhiko Imahashi;Shokichi Tsukamoto;Yukiyasu Ozaw;Katsunori Sasaki;Masafumi Ito;Yutaka Kohgo;Koichi Miyam
Iron overload is a common complication in allogeneic hematopoietic cell transplantation (HCT). We studied the prevalence of iron overload using serum ferritin from 122 allogeneic HCT survivors who had survived a median of 1259 (range 134–4261) days. We also quantified iron overload by determining non-transferrin-bound iron (NTBI), which reflects iron overload more directly than ferritin, and compared the results with those of the ferritin assay. Fifty-two patients (43 %) showed hyperferritinemia (HF) (serum ferritin >1000 ng/mL), and there was a moderate correlation between serum ferritin and the number of transfused red blood cell units (ρ = 0.71). In multivariate analyses, HF was a significant risk factor for liver dysfunction (P= 0.0001) and diabetes (P= 0.02), and was related to a lesser extent with performance status (P= 0.08). There was a significant correlation between serum ferritin and NTBI (ρ = 0.59); however, the association of NTBI with these outcomes was weaker than that of serum ferritin. In conclusion, serum ferritin is a good surrogate marker of iron overload after allogeneic HCT, and reflects organ damage more accurately than NTBI.